The Thoracic Footprint of Hepatocellular Carcinoma: A Mechanism-Based Imaging Narrative Review
Authors:
- Carmen Georgiana Pitusac PrisacaruCPCarmen Georgiana Pitusac Prisacaru
- Ramona CadarRCRamona Cadar
- Cristian Dumitru LupascuCLCristian Dumitru Lupascu
- David TomaDTDavid Toma
- Adriana Loredana PintilieAPAdriana Loredana Pintilie
- Tudor BirladeanuTBTudor Birladeanu
- Ruxandra StirbuRSRuxandra Stirbu
- Raluca Teodora TironRaluca Teodora Tiron
- Roxana CobzariuRCRoxana Cobzariu
- Radu Crisan DabijaRadu Crisan Dabija
- Corina Lupascu UrsulescuCUCorina Lupascu Ursulescu
Open Access
- 22 September 2026
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3072
Abstract
A thoracic finding in a patient with hepatocellular carcinoma (HCC) may represent metastatic disease, vascular extension, treatment-related injury, or a complication of cirrhosis, and each carries different implications for staging and care. The mechanism behind the finding therefore matters as much as the finding itself. We searched the PubMed/MEDLINE database for articles published up to August 2026 and screened the reference lists of retrieved articles for additional relevant publications. The narrative review is organised into four domains: direct oncological involvement, vascular dissemination, treatment-related injury, and cirrhosis-associated mimics. Within each domain, computed tomography (CT) provides most of the chest assessment, while magnetic resonance imaging, echocardiography, and angiography address more specific anatomical or diagnostic questions. We next discuss common patterns of pulmonary metastasis alongside benign nodules common in transplant candidates, and the biological and small-lesion limitations of functional imaging. Thoracic findings gain meaning in the context of hepatic disease, vascular anatomy, and treatment history. Enhancement and alpha-fetoprotein have never been validated as noninvasive rule-out tests for pulmonary metastasis, so the choice between sampling and surveillance rests on multidisciplinary judgement of the costs of uncertainty, procedural feasibility, and evidence strength.Keywords
This publication has 87 references indexed in Scilit:
- Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case reportRespirology Case Reports, 2023
- Bilateral endobronchial metastases from hepatocellular carcinoma (HCC): A case report with literature reviewRespirology Case Reports, 2023
- EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Hepatocellular carcinoma: metastatic pathways and extra-hepatic findingsAbdominal Radiology, 2021
- Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence‐Based Review and GuidanceHepatology, 2020
- Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A‐VENA CriteriaLiver Transplantation, 2018
- Pulmonary nodules in liver transplant candidates with hepatocellular carcinoma: Imaging characteristics and clinical outcomesLiver Transplantation, 2015
- High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameterSurgery Today, 2013
- Surgical impacts of an en bloc resection of the diaphragm for hepatocellular carcinoma with gross diaphragmatic involvementSurgery Today, 2011
- Pleural and pulmonary staining at inferior phrenic arteriography mimicking a tumor staining of hepatocellular carcinomaCardioVascular and Interventional Radiology, 2000